Know Cancer

or
forgot password
  • cancer clinical trials in hinsdale, IL

  • Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma

    Hinsdale, Illinois 60521
    Carcinoma, Hepatocellular
    A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

    Hinsdale, Illinois 60521
    Persistent or Recurrent Cutaneous T-Cell Lymphoma
    Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Endometrial Cancer, Sarcoma
    Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Vulvar Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Breast Cancer
    Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Liver Cancer, Metastatic Cancer
    Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer

    Hinsdale, Illinois 60521
    Hot Flashes, Prostate Cancer
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Kidney Cancer
    Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Lymphoma
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

    Hinsdale, Illinois 60521
    Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastases, Neoplasm
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Pancreatic Cancer
    Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Pancreatic Cancer
    Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Anemia, Fatigue, Prostate Cancer
    A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

    Hinsdale, Illinois 60521
    Liposarcoma, Leiomyosarcoma, Neoplasms, Connective and Soft Tissue, Neoplasms, Adipose Tissue, Neoplasms, Muscle Tissue, Neoplasms by Histologic Type, Sarcoma
    Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Lung Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Lung Cancer
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Vulvar Cancer
    Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Cervical Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Pancreatic Cancer
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Multiple Myeloma, Plasma Cell Neoplasm
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Breast Cancer
    Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    Gynecologic Oncology
    Hinsdale, Illinois 60521
    Ovarian Cancer, Primary Peritoneal Carcinoma
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Hinsdale, Illinois 60521
    Breast Neoplasms, Neoplasm Metastasis
    Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

    Hinsdale, Illinois 60521
    Lymphoma, Non-Hodgkin's Lymphoma
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Endometrial Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Cervical Cancer